Source:http://linkedlifedata.com/resource/pubmed/id/17327291
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-14
|
pubmed:abstractText |
To review the literature concerning the use of hypertonic saline (HS) in patients with cystic fibrosis and explain the rationale for its use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1542-6270
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Hypertonic saline treatment of cystic fibrosis.
|
pubmed:affiliation |
Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, UK HealthCare, Lexington, KY 40536, USA.
|
pubmed:publicationType |
Journal Article,
Review
|